Literature DB >> 19119184

Bacterial infection of Smad3/Rag2 double-null mice with transforming growth factor-beta dysregulation as a model for studying inflammation-associated colon cancer.

Lillian Maggio-Price1, Piper Treuting, Helle Bielefeldt-Ohmann, Audrey Seamons, Rolf Drivdahl, Weiping Zeng, LapHin Lai, Mark Huycke, Susan Phelps, Thea Brabb, Brian M Iritani.   

Abstract

Alterations in genes encoding transforming growth factor-beta-signaling components contribute to colon cancer in humans. Similarly, mice deficient in the transforming growth factor-beta signaling molecule, Smad3, develop colon cancer, but only after a bacterial trigger occurs, resulting in chronic inflammation. To determine whether Smad3-null lymphocytes contribute to increased cancer susceptibility, we crossed Smad3-null mice with mice deficient in both B and T lymphocytes (Rag2(-/-) mice). Helicobacter-infected Smad3/Rag2-double knockout (DKO) mice had more diffuse inflammation and increased incidence of adenocarcinoma compared with Helicobacter-infected Smad3(-/-) or Rag2(-/-) mice alone. Adoptive transfer of WT CD4(+)CD25(+) T-regulatory cells provided significant protection of Smad3/Rag2-DKO from bacterial-induced typhlocolitis, dysplasia, and tumor development, whereas Smad3(-/-) T-regulatory cells provided no protection. Immunohistochemistry, real-time reverse transcriptase-polymerase chain reaction, and Western blot analyses of colonic tissues from Smad3/Rag2-DKO mice 1 week after Helicobacter infection revealed an influx of macrophages, enhanced nuclear factor-kappaB activation, increased Bcl(XL)/Bcl-2 expression, increased c-Myc expression, accentuated epithelial cell proliferation, and up-regulated IFN-gamma, IL-1alpha, TNF-alpha, IL-1beta, and IL-6 transcription levels. These results suggest that the loss of Smad3 increases susceptibility to colon cancer by at least two mechanisms: deficient T-regulatory cell function, which leads to excessive inflammation after a bacterial trigger; and increased expression of proinflammatory cytokines, enhanced nuclear factor-kappaB activation, and increased expression of both pro-oncogenic and anti-apoptotic proteins that result in increased cell proliferation/survival of epithelial cells in colonic tissues.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19119184      PMCID: PMC2631344          DOI: 10.2353/ajpath.2009.080485

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  64 in total

1.  The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer.

Authors:  E M El-Omar; M Carrington; W H Chow; K E McColl; J H Bream; H A Young; J Herrera; J Lissowska; C C Yuan; N Rothman; G Lanyon; M Martin; J F Fraumeni; C S Rabkin
Journal:  Nature       Date:  2001-07-05       Impact factor: 49.962

2.  Identification of genes involved in mucosal defense and inflammation associated with normal enteric bacteria.

Authors:  H Ogawa; K Fukushima; I Sasaki; S Matsuno
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-09       Impact factor: 4.052

3.  Cancer: an inflammatory link.

Authors:  Fran Balkwill; Lisa M Coussens
Journal:  Nature       Date:  2004-09-23       Impact factor: 49.962

Review 4.  Nuclear factor-kappaB in cancer development and progression.

Authors:  Michael Karin
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

Review 5.  Traps to catch unwary oncogenes.

Authors:  A O Hueber; G I Evan
Journal:  Trends Genet       Date:  1998-09       Impact factor: 11.639

6.  Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/- mice results in colitis that progresses to dysplasia.

Authors:  Lillian Maggio-Price; Helle Bielefeldt-Ohmann; Piper Treuting; Brian M Iritani; Weiping Zeng; Andrea Nicks; Mark Tsang; Donna Shows; Phil Morrissey; Joanne L Viney
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

7.  Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice.

Authors:  A Burich; R Hershberg; K Waggie; W Zeng; T Brabb; G Westrich; J L Viney; L Maggio-Price
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-09       Impact factor: 4.052

8.  CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice.

Authors:  Susan E Erdman; Jane J Sohn; Varada P Rao; Prashant R Nambiar; Zhongming Ge; James G Fox; David B Schauer
Journal:  Cancer Res       Date:  2005-05-15       Impact factor: 12.701

9.  Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer.

Authors:  Megan M Garrity-Park; Edward V Loftus; Sandra C Bryant; William J Sandborn; Thomas C Smyrk
Journal:  Am J Gastroenterol       Date:  2008-02       Impact factor: 10.864

10.  CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice.

Authors:  Susan E Erdman; Varada P Rao; Theofilos Poutahidis; Melanie M Ihrig; Zhongming Ge; Yan Feng; Michal Tomczak; Arlin B Rogers; Bruce H Horwitz; James G Fox
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

View more
  21 in total

Review 1.  A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects.

Authors:  Harold Tjalsma; Annemarie Boleij; Julian R Marchesi; Bas E Dutilh
Journal:  Nat Rev Microbiol       Date:  2012-06-25       Impact factor: 60.633

2.  Lack of effect of murine norovirus infection on a mouse model of bacteria-induced colon cancer.

Authors:  Karen C Lencioni; Rolf Drivdahl; Audrey Seamons; Piper M Treuting; Thea Brabb; Lillian Maggio-Price
Journal:  Comp Med       Date:  2011-06       Impact factor: 0.982

3.  Isolation of Helicobacter spp. from mice with rectal prolapses.

Authors:  Cassandra L Miller; Sureshkumar Muthupalani; Zeli Shen; James G Fox
Journal:  Comp Med       Date:  2014-06       Impact factor: 0.982

4.  Effect of Chronic Vitamin D Deficiency on the Development and Severity of DSS-Induced Colon Cancer in Smad3-/- Mice.

Authors:  Stacey M Meeker; Audrey Seamons; Piper M Treuting; Jisun Paik; Thea Brabb; Charlie C Hsu; William M Grady; Lillian Maggio-Price
Journal:  Comp Med       Date:  2020-02-03       Impact factor: 0.982

Review 5.  TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota.

Authors:  Sozaburo Ihara; Yoshihiro Hirata; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2017-05-22       Impact factor: 7.527

6.  4-hydroxy-2-nonenal mediates genotoxicity and bystander effects caused by Enterococcus faecalis-infected macrophages.

Authors:  Xingmin Wang; Yonghong Yang; Danny R Moore; Susan L Nimmo; Stanley A Lightfoot; Mark M Huycke
Journal:  Gastroenterology       Date:  2011-11-19       Impact factor: 22.682

7.  Helicobacter cinaedi induced typhlocolitis in Rag-2-deficient mice.

Authors:  Zeli Shen; Yan Feng; Barry Rickman; James G Fox
Journal:  Helicobacter       Date:  2014-11-08       Impact factor: 5.753

8.  Macrophages promote fibroblast growth factor receptor-driven tumor cell migration and invasion in a CXCR2-dependent manner.

Authors:  Laura R Bohrer; Kathryn L Schwertfeger
Journal:  Mol Cancer Res       Date:  2012-08-14       Impact factor: 5.852

9.  Helicobacter bilis Infection Alters Mucosal Bacteria and Modulates Colitis Development in Defined Microbiota Mice.

Authors:  Todd Atherly; Curtis Mosher; Chong Wang; Jesse Hostetter; Alexandra Proctor; Meghan W Brand; Gregory J Phillips; Michael Wannemuehler; Albert E Jergens
Journal:  Inflamm Bowel Dis       Date:  2016-11       Impact factor: 5.325

10.  Increased dietary vitamin D suppresses MAPK signaling, colitis, and colon cancer.

Authors:  Stacey Meeker; Audrey Seamons; Jisun Paik; Piper M Treuting; Thea Brabb; William M Grady; Lillian Maggio-Price
Journal:  Cancer Res       Date:  2014-06-17       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.